Genotype and phenotype of glutathione S-transferase μ in testicular cancer patients

Pharmacogenetics

Volumn 7, Issue 1, 1997, Pages 21-25

  Vistisen, Kirsten ^a   Priemé, Helene ^a   Okkels, Henrik ^b   Vallentin, Susanne ^c   Loft, Steffen ^a   Olsen, Joørgen H ^d   Poulsen, Henrik E ^a,e,f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

glutathione S transferase ; population based; testicular cancer

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEMINOMA; TESTIS CANCER;

ADULT; CASE-CONTROL STUDIES; COFFEE; CRYPTORCHIDISM; DENMARK; EXERCISE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; ISOENZYMES; MALE; PHENOTYPE; SEMINOMA; SMOKING; TESTICULAR NEOPLASMS;

LONCHOCARPUS GLAUCIFOLIUS;

EID: 0030909684     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199702000-00003     Document Type: Article

References (22)

1. Abratt RP, Reddi VB, Sarembock LA. Testicular cancer and cryptorchidism. Br J Urol 1992: 70, 656-659.
2. Autrup H, Vestergaard AB, Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 1995: 16, 1305-1309.
3. Barone JJ, Roberts HR. Caffeine consumption. Fd Chem Toxic 1996: 34, 119-129.
4. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993: 30, 281-380.
5. Board PG. Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 1981: 33, 36-43.
6. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and controls. Cancer Res 1993: 53, 1004-1011.
7. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: A case-control study. Cancer Res 1994: 54, 4103-4111.
8. Campbell E, Takahashi Y, Abramovitz M, Peretz M, Listowsky I. A distinct human testis and brain μ-class glutathione S-transferase. J Biol Chem 1990: 265, 9188-9193.
9. Forman D, Gallagher R, Moller H, Swerdlow TJ. Aetiology and epidemiology of testicular cancer: Report of consensus group. Prog Clin Biol Res 1990: 357, 245-253.
10. Forman D, Oliver RTD, Brett AR, Marsh SGE, Moses JH, Bodmer JG, Chilvers CED, Pike MC. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA Class I sib-pair analysis. Br J Cancer 1992: 65, 255-262.
11. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991: 51, 94-98.
12. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Molec Biol 1995: 30, 445-601.
13. Klys HS, Whillis D, Howard G, Harrison DJ. Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer 1992: 66, 589-593.
14. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993: 23, 8-15.
15. Morel F, Schulz WA, Sies H. Gene structure and regulation of expression of human glutalhione S-transferase alpha. Biol Chem Hoppe-Seyler 1994: 375, 641-649.
16. Nebert DW, McKinnon RA, Puga A. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer. DNA Cell Biol 1996: 15, 273-280.
17. Nicholson PW, Harland SJ. Inheritance and testicular cancer. Br J Cancer 1995: 71, 421-426.
18. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer incidence in live continents IARC Scientific Publications 120: Lyon: International Agency for Research on Cancer, 1992.
19. Prignot J. Quantification and chemical markers of tobacco exposure. Eur J Respir Dis 1987: 70, 1-7.
20. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 1995: 159, 113-121.
21. Seidegaard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988: 85, 7293-7297.
22. Westergaard T, Olsen JH, Frisch M, Kroman N, Nielsen JW, Melbye M. Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A populations-based study. Int J Cancer 1996: 66, 627-631.